A Phase 3, Open-Label, Randomized Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical Trial Grant
Awarded By
BeOne Medicines USA, Inc.
Start Date
December 12, 2025
End Date
January 1, 2031
Awarded By
BeOne Medicines USA, Inc.
Start Date
December 12, 2025
End Date
January 1, 2031